Advertisement
Screener

Takeda Pharmaceutical Company Limited (TKPHF) Form 6-K: Report of foreign private issuer

Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-14: Form 6-K; Period of report 2026-09-14; Description 6-K; Document form6k_091426.htm.
  • 2026-08-31: Form 6-K; Period of report 2026-08-28; Description 6-K; Document form6k_082826.htm.
  • 2026-08-06: Form 6-K; Period of report 2026-08-05; Description 6-K; Document form6k_080526.htm.
  • 2026-07-30: Form 6-K; Period of report 2026-07-30; Description 6-K; Document form6k_073026.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-146-K2026-09-146-Kform6k_091426.htm
2026-08-316-K2026-08-286-Kform6k_082826.htm
2026-08-066-K2026-08-056-Kform6k_080526.htm
2026-07-306-K2026-07-306-Kform6k_073026.htm
2026-07-096-K2026-07-096-Kform6k_070926.htm
2026-07-086-K2026-07-086-Kform6k_070826.htm
2026-06-296-K2026-06-296-Kform6k_062926.htm
2026-06-266-K2026-06-266-Kform6k_062626.htm
2026-06-246-K2026-06-246-Kform6k-3_062426.htm
2026-06-246-K2026-06-246-Kform6k-2_062426.htm
2026-06-246-K2026-06-246-Kform6k-1_062426.htm
2026-06-096-K2026-06-096-Kform6k_060926.htm
2026-06-056-K2026-06-056-Kform6k_2x060526.htm
2026-06-056-K2026-06-056-Kform6k_060526.htm
2026-06-016-K2026-06-016-Kform6k_060126.htm
2026-05-266-K2026-05-266-Kform6k_052626x1.htm
2026-05-266-K2026-05-266-Kform6k_052626x2.htm
2026-05-266-K2026-05-266-Kform6k_052626x3.htm
2026-05-266-K2026-05-266-Kform6k_052626x4.htm
2026-05-266-K2026-05-266-Kform6k_052626x5.htm
2026-05-196-K2026-05-196-Kform6k_051926.htm
2026-05-136-K2026-05-136-Kform6k-2_051326.htm
2026-05-136-K2026-05-136-Kexhibit991_051326.htm
2026-03-306-K2026-03-306-Kform6k_033026.htm
2026-03-266-K2026-03-266-Kform6k_032626.htm
2026-03-256-K2026-03-256-Kform6k_032526.htm
2026-03-026-K2026-03-026-Kform6k_030226.htm
2026-02-106-K2026-02-106-Kform6k_021026.htm
2026-01-296-K2026-01-296-Kform6k_012926.htm